15 June 2020>: Clinical Research
LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis
Ying Wang CDE* , Danli Xin ABCE , Lei Zhou BCDFDOI: 10.12659/MSM.920886
Med Sci Monit 2020; 26:e920886
Figure 4 Sensitivities of retinoblastoma cells to carboplatin and adriamycin. (A–D) Cell viability was assessed by CCK-8 assay in Y79 and Weri-RB-1 cells transfected with si-NC, si-LINC00152#1, anti-miR-NC, anti-miR-613, or si-LINC00152#1+anti-miR-613, untransfected cells as internal control, following treated with carboplatin and adriamycin in different concentrations. CCK-8 – Cell Counting Kit-8.